Institutional Ownership
Adial Pharmaceuticals Inc
CUSIP 00688A304COM NEWQ1 2026
Institutional Holders
12
13F filers
Shares Held
29.3K
Aggregate institutional
Institutional Value
$52.5K
Q1 2026
Net New Holders
+12
12 new · 0 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions12
Increased0
Decreased0
Sold out0
Institutional Holders
12 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 24.2K | $43.4K | +24.2K | New |
| 2 | Manchester Capital Management LLC | 1.9K | $3.4K | +1.9K | New |
| 3 | Tower Research Capital LLC (Trc) | 1.4K | $2.4K | +1.4K | New |
| 4 | Blackrock, Inc. | 1.1K | $2.0K | +1.1K | New |
| 5 | Ubs Group AG | 542 | $970 | +542 | New |
| 6 | Morgan Stanley | 50 | $90 | +50 | New |
| 7 | Sbi Securities Co., Ltd. | 47 | $84 | +47 | New |
| 8 | Caitong International Asset Management Co., Ltd | 15 | $27 | +15 | New |
| 9 | Wells Fargo & Company/Mn | 6 | $11 | +6 | New |
| 10 | Northwestern Mutual Wealth Management Co | 4 | $7 | +4 | New |
2 more institutional holders on Premium
See every fund holding Adial Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders